These inactivating mutations of PHEX cause an increased concentration of FGF23, leading to hyperphosphaturia, hypophosphatemia and low or inappropriately normal serum 1,25(OH)2D concentrations [128]. The gene discussed is FGF23; the disease is hypophosphatemia.